scispace - formally typeset
Search or ask a question
JournalISSN: 1536-0288

Journal of Pain and Palliative Care Pharmacotherapy 

Informa
About: Journal of Pain and Palliative Care Pharmacotherapy is an academic journal published by Informa. The journal publishes majorly in the area(s): Palliative care & Chronic pain. It has an ISSN identifier of 1536-0288. Over the lifetime, 991 publications have been published receiving 13021 citations. The journal is also known as: Journal of Pain & Palliative Care Pharmacotherapy & J. Pain Palliat. Care Pharmacother..


Papers
More filters
Journal ArticleDOI
TL;DR: The National Academy of Sciences through its Institute of Medicine (IOM) has produced a major scholarly assessment of pain in America as mentioned in this paper, which is a tremendous contribution to the evolving nec...
Abstract: The National Academy of Sciences through its Institute of Medicine (IOM) has produced a major scholarly assessment of pain in America. This document is a tremendous contribution to the evolving nec...

1,598 citations

Journal ArticleDOI
TL;DR: There does appear to be sufficient evidence to at least make addressing chronic pain a high priority alongside other chronic diseases as well as to conduct more research, particularly regarding cost.
Abstract: The objective of this study was to assess recent data on the prevalence of chronic pain as part of chronic diseases; the prevalence of chronic pain as a chronic condition in its own right; the costs attributed to chronic pain; and the European Union (EU) policies to addressing chronic pain. Recent literature was reviewed for data on the prevalence and cost implications of chronic pain in the EU. Following on from an earlier systematic review, 8 databases were searched for prevalence and 10 for cost information from 2009 to 2011 and relevant EU organizations were contacted. Ten cost and 29 prevalence studies were included from the 142 full papers screened. The general adult population reported an average chronic pain prevalence of 27%, which was similar to those for common chronic conditions. Fibromyalgia had the highest unemployment rate (6%; Rivera et al., Clin Exp Rheumatol. 2009;27[Suppl 56]:S39–S45) claims for incapacity benefit (up to 29.9%; Sicras-Mainar et al., Arthritis Res Ther. 2009;11:R...

216 citations

Journal ArticleDOI
TL;DR: A rough but simple method for estimating the total population need for opioids for treating all various types of moderate and severe pain at the country, regional, and global levels is proposed.
Abstract: The objective of this study was to propose a rough but simple method for estimating the total population need for opioids for treating all various types of moderate and severe pain at the country, regional, and global levels. We determined per capita need of strong opioids for pain related to three important pain causes for 188 countries. These needs were extrapolated to the needs for all the various types of pain by using an adequacy level derived from the top 20 countries in the Human Development Index. By comparing with the actual consumption levels for relevant strong opioid analgesics, we were able to estimate the level of adequacy of opioid consumption for each country. Good access to pain management is rather the exception than the rule: 5.5 billion people (83% of the world's population) live in countries with low to nonexistent access, 250 million (4%) have moderate access, and only 460 million people (7%) have adequate access. Insufficient data are available for 430 million (7%). The consumption of opioid analgesics is inadequate to provide sufficient pain relief around the world. Only the populations of some industrialized countries have good access. Policies should seek a balance between maximizing access for medical use and minimizing abuse and dependence. Countries should aim to increase the medical consumption to the magnitude needed to address the totality of moderate and severe pain.

186 citations

Journal ArticleDOI
TL;DR: A meta-analysis of two studies in type 1 diabetes found a significantly reduced risk of developing clinical neuropathy in those with enhanced glucose control, but there is a big BUT, both types of diabetic participants also had a significant increase in severe adverse events including hypoglycemic events.
Abstract: This review should be cited as: Callaghan BC, Little AA, Feldman EL, Hughes RAC. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database of Systematic Reviews 20...

185 citations

Journal ArticleDOI
TL;DR: General dosing guidelines, dosage conversions from other opioids and pharmacokinetic issues in Special populations are discussed and unique and clinically important elements of methadone disposition including its absorption profile, distribution, and metabolism/excretion are summarized.
Abstract: Methadone is a synthetic opioid that is effective for the relief of moderate-to-severe pain and for the treatment of opioid dependence. The pharmacokinetics of methadone differ from those of morphi...

182 citations

Performance
Metrics
No. of papers from the Journal in previous years
YearPapers
202323
202254
202134
202030
201917
201838